166 related articles for article (PubMed ID: 35241306)
1. Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes.
Okanishi T; Fujii Y; Sakuma S; Shiraishi H; Motoi H; Yazaki K; Enoki H; Fujimoto A
Brain Dev; 2022 Jun; 44(6):380-385. PubMed ID: 35241306
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
3. Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study.
Mo F; Meletti S; Belcastro V; Quadri S; Napolitano M; Bello L; Dainese F; Scarpelli M; Florindo I; Mascia A; Pauletto G; Bruno F; Pellerino A; Giovannini G; Polosa M; Sessa M; Conti Nibali M; Di Gennaro G; Gigli GL; Pisanello A; Cavallieri F; Rudà R
J Neurooncol; 2022 May; 157(3):551-559. PubMed ID: 35397759
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the efficacy and influencing factors of sodium channel blockers in the treatment of focal epilepsy in infants under 6 months of age].
Ma YP; Deng J; Fu ZR; Chen CH; Wang XH; Wang X; Weng JW; Shen YH
Zhonghua Er Ke Za Zhi; 2023 Nov; 61(11):983-988. PubMed ID: 37899337
[No Abstract] [Full Text] [Related]
5. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C
Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655
[TBL] [Abstract][Full Text] [Related]
6. Lacosamide monotherapy for partial onset seizures.
Lattanzi S; Cagnetti C; Foschi N; Provinciali L; Silvestrini M
Seizure; 2015 Apr; 27():71-4. PubMed ID: 25891931
[TBL] [Abstract][Full Text] [Related]
7. Retrospective comparison of efficacy of levetiracetam and lacosamide add-on treatments in patients with partial onset seizure.
Acar T; Aras YG
Ideggyogy Sz; 2018 May; 71(5-06):197-204. PubMed ID: 29889462
[TBL] [Abstract][Full Text] [Related]
8. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.
Muñoz-Lopetegi A; López-González FJ; Rodríguez-Osorio X; Pato Pato A; Bellas Lamas P; Abella-Corral J; Castro Vilanova MD; Garea MJ; Gil López JA; Ruiz-Martínez J; Poza JJ
Epilepsy Res; 2018 Sep; 145():51-54. PubMed ID: 29890341
[TBL] [Abstract][Full Text] [Related]
9. Perampanel and lacosamide monotherapy in pediatric patients with newly diagnosed focal epilepsy: A prospective study evaluating efficacy, tolerability, and behavior.
Zhou R; Qu R; Liu M; Huang DP; Zhou JY; Chen Y; Chen XQ
Epilepsy Behav; 2023 Sep; 146():109353. PubMed ID: 37481960
[TBL] [Abstract][Full Text] [Related]
10. Lacosamide: A Review in Focal-Onset Seizures in Patients with Epilepsy.
Hoy SM
CNS Drugs; 2018 May; 32(5):473-484. PubMed ID: 29785508
[TBL] [Abstract][Full Text] [Related]
11. The challenges of assessing effectiveness of lacosamide using electronic medical record databases.
Kalilani L; Halpern R; Seare J; Dedeken P
Epilepsy Behav; 2018 Aug; 85():195-199. PubMed ID: 30032807
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation.
Giráldez BG; Toledano R; García-Morales I; Gil-Nagel A; López-González FJ; Tortosa D; Ojeda J; Serratosa JM
Seizure; 2015 Jul; 29():119-22. PubMed ID: 26076854
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting.
Sanmartí-Vilaplana F; Díaz-Gómez A
Epilepsy Behav; 2018 Feb; 79():130-137. PubMed ID: 29287216
[TBL] [Abstract][Full Text] [Related]
14. Lacosamide add-on therapy for partial epilepsy.
Weston J; Shukralla A; McKay AJ; Marson AG
Cochrane Database Syst Rev; 2015 Jun; (6):CD008841. PubMed ID: 26077821
[TBL] [Abstract][Full Text] [Related]
15. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
[TBL] [Abstract][Full Text] [Related]
18. Conversion to lacosamide monotherapy in the treatment of focal epilepsy: results from a historical-controlled, multicenter, double-blind study.
Wechsler RT; Li G; French J; O'Brien TJ; D'Cruz O; Williams P; Goodson R; Brock M;
Epilepsia; 2014 Jul; 55(7):1088-98. PubMed ID: 24915838
[TBL] [Abstract][Full Text] [Related]
19. Lacosamide monotherapy in clinical practice: A retrospective chart review.
Villanueva V; Giráldez BG; Toledo M; De Haan GJ; Cumbo E; Gambardella A; De Backer M; Joeres L; Brunnert M; Dedeken P; Serratosa J
Acta Neurol Scand; 2018 Sep; 138(3):186-194. PubMed ID: 29542107
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]